indicating the potential interaction of APOL1 genotype with the environmental factors in CKD pathogenesis and progression. In normal human kidney, the APOL1 protein localizes to the proximal tubules, podocytes and extraglomerular arterioles and small arteries of endothelium (7) . Although the exact pathogenic mechanism by which APOL1 variants make patients susceptible to CKD is not known, diminished APOL1 expression is reported in the podocytes of HIVAN and FSGS kidney biopsies compared to normal kidneys (2, 4) . The other potential mechanisms include activation of inflammation, impairment of kidney microcirculation, vascular endothelial dysfunction, cation pore formation and activation of protein kinase R (9) . The APOL1 variants can be cytotoxic to proximal tubular cells and leading to podocytic apoptosis (10) (11) (12) . Further, APOL1 variants form cation K(+) pores in the plasma membrane that facilitate the reduction in intracellular K+ and subsequent activation of stress kinases pathways that exert nephrotoxicity (13) . It is also reported that the APOL1 risk variants are associated with collapsing glomerulopathy (14) . Furthermore, elevated CKD risk associated with APOL1 risk variants is modulated by other genetic, environmental and factors (15) .
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Another mechanism for CKD is that the soluble urokinase plasminogen activator receptor (suPAR) and APOL1 variants synergize to activate αvβ3 integrin on podocytes. Activation of podocyte integrin leads to deregulation of the actin cytoskeleton and consequently results in podocyte effacement and loss (16) . Inflammation is the additional factor that involved in the renal injury. The signaling pathways of interferon-γ, tumor necrosis factor-α and p53 induce expression the APOL1 (17) . A recent study examined the molecular behavior of APOL1 in mitochondrial dysfunction in vitro. This study demonstrated that the APOL1 risk variants could translocate into mitochondria and bind to the permeability transition pore components, leading to cell death (18) . APOL1 risk variants also diminish mitochondrial superoxide dismutase 2 and catalase and make the cell susceptible to oxidative stress, leading to mitochondrial dysfunction (19) . In conclusion, the understanding of non-diabetic nephropathy has been enhanced by the discovery of the association of APOL1 with a spectrum of nephropathies. Outlining the renal injury pathways and uncovering the relationships between APOL1 and renal diseases brings hopeful horizons for effective therapy of these diseases. However, our knowledge on role of APOL1 in CKD is still in its toddling stage, further research is needed for better understanding the pathogenesis of renal injury in patients with the high-risk genotype.
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